Initial Treatment Strategies for Bronchiectasis and NTM Pulmonary Disease
ABOUT THIS EPISODE
Originally aired: July 1, 2025
In this podcast episode, host Doreen Addrizzo-Harris, MD, FCCP, is joined by Keren Bakal, MD, and Amy Springer, MSN, FNP-C, to explore initial treatment strategies for bronchiectasis and nontuberculous mycobacterial (NTM) pulmonary disease. The conversation delves into the critical role of airway clearance therapy, challenges in selecting individualized treatments, and the importance of patient education. The experts also discuss the latest guidelines for managing nodular and cavitary NTM lung disease, including when to initiate treatment vs monitoring, as well as strategies for managing common drug toxicities. Additionally, they examine comorbidities often seen in patients with bronchiectasis, such as gastrointestinal disorders, sinus disease, and psychosocial factors like anxiety and depression.
This episode is part of CHEST’s Bridging Specialties®: Timely Diagnosis for NTM Pulmonary Disease and Bronchiectasis program. LEARN MORE »
This program is produced in partnership with CHEST and is sponsored by Insmed Incorporated.
HOST
Doreen J. Addrizzo-Harris, MD, FCCP
Fiona and Stanley Druckenmiller Professor of Pulmonary, Critical Care, and Sleep Medicine
Director, NYULH Bronchiectasis and NTM Clinical and Translational Program
NYU Grossman School of Medicine
New York, NY
PANELISTS
Keren Bakal, MD
Clinical Attending, Pulmonary and Critical Care Medicine
Overlook Medical Center/Atlantic Health System
Summit Health
Livingston, NJ
Amy Springer, MSN, FNP-C
Senior Nurse Practitioner
NYULH Bronchiectasis and NTM Clinical and Translational Program
Division of Pulmonary, Critical Care, and Sleep Medicine
NYU Langone Health
New York, NY